期刊文献+

5型和35型腺病毒纤毛蛋白的原核表达及活性验证

Prokaryotic Expression and Activity Detection of Ad5/Ad35 Fiber Gene
原文传递
导出
摘要 目的:原核表达5型腺病毒纤毛蛋白(Ad5 fiber)和35型腺病毒纤毛蛋白(Ad35 fiber),并对蛋白活性进行初步分析。方法:将重组质粒pET28a-Ad5 fiber和pET28a-Ad35 fiber转化入E.coli BL21(DE3),IPTG诱导表达后,经Ni-NTA凝胶珠亲和纯化,用SDS-PAGE鉴定纯化蛋白,并用蛋白竞争性实验验证纯化蛋白的活性。结果:转化溶原菌后能够表达目的蛋白,Ad35 fiber蛋白对Ad5(5型腺病毒)感染无影响,只能阻断Ad5F35(5型腺病毒纤毛被替换为35型腺病毒纤毛的嵌合腺病毒)对细胞的感染;Ad5 fiber蛋白对嵌合腺病毒Ad5F35感染无影响,只能抑制Ad5对细胞的感染。结论:成功表达具有生物活性的5型和35型腺病毒纤毛蛋白,为进一步研究嵌合腺病毒Ad5F35感染细胞的机制奠定基础。 Aim: To construct the prokaryotic expression vector for Ad5 fiber and Ad35 fiber genes, purify proteins and study the activity. Methods: Recombinant plasmid pET28a-Ad5 fiber and pET28a-Ad35 fiber were transformed into E. coli Bl21 (DE3) and the proteins expression were induced with IPTG. The expressed proteins Ad5 fiber and Ad35 fiber were purified by Ni2~ affinity chromatography and identified by SDS-PAGE. The bioactivity of proteins Ad5 fiber and Ad35 fiber were certificated by competitive binding method. Results: The proteins Ad5 fiber and Ad35 fiber can be detected in the supernatant. The proteins Ad5 fiber specifically inhibited the infectivity of the Ad5 virus in a dose-dependent manner, while had no effect on the Ad5F35- mediated gene transfer. The proteins Ad35 fiber blocked the Ad5F35-mediated gene transfer in a dose-dependent manner and had no effect on the infectivity of the Ad5 virus in competition experiments. Conclusion: Recombinant vectors Ad5 fiber and Ad35 fiber were constructed successfully. The proteins Ad5 fiber and Ad35 fiber could specifically bind with different receptors. The study will lay a foundation for the investigation on the mechanism of Ad5F35 infection.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2013年第12期15-20,共6页 China Biotechnology
基金 "重大新药创制"科技重大专项"十一五"计划项目(2009ZX09103-708) 国家自然科学基金(31100664 31300737 81303292) 东莞市科技计划项目(2011105102027)资助项目
关键词 嵌合腺病毒载体 腺病毒纤毛蛋白 原核表达 Adenoviral vector Adenovirus fiber protein Prokaryotic expression
  • 相关文献

参考文献11

  • 1Clay T M, Custer M C, Sachs J, et al. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol, 1999, 163 : 507-513.
  • 2Morgan R A, Dudley M E, Wunderlich J R, et al. Cancerregression in patients after transfer of genetically engineered lymphocytes. Science, 2006, 314: 126-129.
  • 3Johnson L A, Morgan R A, Dudley M E, et al. Gene therapy with human and mouse T cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood, 2009, 114 : 535-546.
  • 4Uckert W, Becker C, Gladow M, et al. Efficient gene transfer into primary human CD8 T lymphocytes by MuLV-10A1 retrovirus pseudotype. Hum Gene Ther, 2000,11 : 1005-1014.
  • 5Uckert W, Schumacher T N. TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008. Cancer Immunol Immunother, 2009, 58: 809-822.
  • 6Nicklin S A, Wu E, Nemerow G R, et al. The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther, 2005, 12: 384-393.
  • 7Tomko R P, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgrou PC adenoviruses and grou PB coxsackieviruses. Proc Natl Acad Sci USA, 1997, 94: 3352- 3356.
  • 8Gaggar A, Shayakhmetov D M, Lieber A. CD46 is a cellular receptor for grou PB adenoviruses. Nat Med, 2003, 9: 1408- 1412.
  • 9Schroers R, Hildebrandt Y, Hasenkamp J, et al. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Ex PHematol, 2004, 32: 536-546.
  • 10Shayakhmetov D M, Papayannopoulou T, Stamatoyannopoulos G, et al. Efficient gene transfer into human CD34 ( + ) cells by a retargeted adenovirus vector. J Virol, 2000, 74: 2567-2583.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部